Compared to normal melanocytes, DSG2 was overexpressed in a substantial fraction of human melanoma tissues and cell lines, and its expression in patient tumors was associated with enhanced VM, an enrichment of VM-associated genes and reduced overall survival. This evidence concerns the gene DSG2 and melanoma.